Evidence map›Paper›PMID 25124043›Full record

ArticleThe Journal of biological chemistry2014

Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.

Mumtaz Kasim, Edgar Benko, Aline Winkelmann, Ralf Mrowka, Jonas J Staudacher, Pontus B Persson, Holger Scholz, Jochen C Meier, Michael Fähling

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mumtaz KasimInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin.
Edgar BenkoInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin.
Aline WinkelmannRNA Editing and Hyperexcitability Disorders Helmholtz Group, Max Delbrück Center for Molecular Medicine, D-13125 Berlin, and.
Ralf MrowkaKlinik für Innere Medizin III, AG Experimentelle Nephrologie, Universitätsklinikum Jena, D-07743 Jena, Germany.
Jonas J StaudacherInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin.
Pontus B PerssonInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin.
Holger ScholzInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin.
Jochen C MeierRNA Editing and Hyperexcitability Disorders Helmholtz Group, Max Delbrück Center for Molecular Medicine, D-13125 Berlin, and.
Michael FählingInstitut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, D-10117 Berlin,. Electronic address: michael.faehling@charite.de.
Max Delbrück Center · DEJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The basic helix-loop-helix transcription factor hASH1, encoded by the ASCL1 gene, plays an important role in neurogenesis and tumor development. Recent findings indicate that local oxygen tension is a critical determinant for the progression of neuroblastomas. Here we investigated the molecular mechanisms underlying the oxygen-dependent expression of hASH1 in neuroblastoma cells. Exposure of human neuroblastoma-derived Kelly cells to 1% O2 significantly decreased ASCL1 mRNA and hASH1 protein levels. Using reporter gene assays, we show that the response of hASH1 to hypoxia is mediated mainly by post-transcriptional inhibition via the ASCL1 mRNA 5'- and 3'-UTRs, whereas additional inhibition of the ASCL1 promoter was observed under prolonged hypoxia. By RNA pulldown experiments followed by MALDI/TOF-MS analysis, we identified heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 and hnRNP-R as interactors binding directly to the ASCL1 mRNA 5'- and 3'-UTRs and influencing its expression. We further demonstrate that hnRNP-A2/B1 is a key positive regulator of ASCL1, findings that were also confirmed by analysis of a large compilation of gene expression data. Our data suggest that a prominent down-regulation of hnRNP-A2/B1 during hypoxia is associated with the post-transcriptional suppression of hASH1 synthesis. This novel post-transcriptional mechanism for regulating hASH1 levels will have important implications in neural cell fate development and disease.

Indexed as

Gene Expression Regulation, Neoplastic3' Untranslated Regions5' Untranslated RegionsAnimalsBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorHeterogeneous-Nuclear Ribonucleoprotein Group A-BHumansNeoplasm ProteinsNeuroblastomaPromoter Regions, GeneticRabbitsRats, Wistar3' Untranslated Regions5' Untranslated RegionsAscl1 protein, ratBasic Helix-Loop-Helix ProteinsHeterogeneous-Nuclear Ribonucleoprotein Group A-BhnRNP A2Neoplasm ProteinsASCL1Gene ExpressionhASH1 (Mash1)hnRNP-A2/B1hnRNP-RHypoxiaPost-transcriptional RegulationRNA-binding ProteinRNA Turnover

Identifiers

PMID25124043
PMCPMC4175337
OpenAlexW1996028527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.